International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
International Journal of Celiac Disease. 2021, 9(1), 6-9
DOI: 10.12691/ijcd-9-1-8
Open AccessArticle

The COVID-19 Vaccination Debate: CoV-2 in Celiac Disease: A Pathogen or just along for the Ride?

Aaron Lerner1,

1Chaim Sheba Medical Center, the Zabludowicz Center for Autoimmune Diseases, Tel-Hashomer, Israel

Pub. Date: January 21, 2021

Cite this paper:
Aaron Lerner. The COVID-19 Vaccination Debate: CoV-2 in Celiac Disease: A Pathogen or just along for the Ride?. International Journal of Celiac Disease. 2021; 9(1):6-9. doi: 10.12691/ijcd-9-1-8


SARS-CoV-2, the virus that causes COVID-19, impacts human health all over the world with high morbidity and mortality. Many chronic diseases predispose the patients to be infected, including autoimmune diseases. Despite theoretical and rare exceptions, celiac disease is not a high-risk condition for COVID-19 infection. The present review expends on those potential circumstances that put the CD patients at risk for COVID-19.

celiac disease Coronavirus 2 SARS-CoV-2 COVID-19 risk

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ. 2020. Coronavirus disease 2019–COVID-19. Clin Microbiol Rev 33: e00028-20.
[2]  Lerner A. Are My Patients with Celiac Disease at Higher Risk of COVID-19 Virus? Internat J Celiac Disease. 2020; 8: 35-38
[3]  Lerner A. Covid-19 and the Human Gut: A New Runner on the Tract. Internat J Celiac Disease. 2020; 8: 64-67.
[4]  Perisetti A, Goyal H, Gajendran M, Boregowda U, Mann R, Sharma N. Prevalence, Mechanisms, and Implications of Gastrointestinal mSymptoms in COVID-19. Front. Med. 7: 588711.
[5]  Monteleone G, Ardizzone S. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection? J Crohns Colitis. 2020; 14: 1334-1336.
[6]  Zingone F, D'Odorico A, Lorenzon G, Marsilio I, Farinati F, Savarino EV. Risk of COVID-19 in celiac disease patients. Autoimmun Rev. 2020; 19: 102639.
[7]  Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. Holland: Elsevier, 1989 p.523.
[8]  Amital H, Gershwin EM, Shoenfeld Y. Reshaping the mosaic of autoimmunity. Semin Arthritis. Rheum 2006; 35: 341-343.
[9]  Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms. Viruses. 2019; 11: 762.
[10]  Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, et al., Covid-19 and autoimmunity. Autoimmun Rev. 2020; 19: 102597.
[11]  Gilad Halpert G, Shoenfeld S. SARS-CoV-2, the autoimmune virus. Autoimm Rev. 2020; 19: 102695.
[12]  Mangalmurti N, Hunter CA, Cytokine Storms: Understanding COVID-19. Immunity. 2020; 53: 19-25.
[13]  Woodruff MC, Ramonell RP, Lee F E-H, Sanz I. Clinically identifiable autoreactivity is common in severe SARS-CoV-2 Infection. medRxiv. Preprint. 2020 Oct 23.
[14]  Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020; 69: 1002-1009.
[15]  Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368: m606.
[16]  Fang D, Ma J, Guan J. et al. Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study. Chinese J of Digest. 2020; (12): E005-E005.
[17]  Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020; 51: 843-851.
[18]  Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol. 2020; 35: 744-748.
[19]  Zhang H, Kang Z, Gong H. et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. BioRxiv 927806. Post online Jan 31.
[20]  Wei XS, Wang X, Niu YR, Ye LL, Peng WB, Wang ZH, et al. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19. Clin Gastroenterol Hepatol. 2020; 18: 1753-1759. e2.
[21]  Kam KQ, Yung CF, Cui L, Lin Tzer Pin R, Mak TM, Maiwald M, et al. A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load. Clin Infect Dis. 2020; 71: 847-849.
[22]  Indwiani A, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr. 2020; 14: 407-412.
[23]  Liu Q, Wang R., Qu G et al. Macroscopic autopsy findings in a patient with COVID-19. J Forensic Med. 2020; 36: 1-3.
[24]  Yang Z, Li G, Dai X, Liu G, Li G, Jie Y. Three cases of novel coronavirus pneumonia with viral nucleic acids still positive in stool after throat swab detection turned negative. Chin J Dig. 2020; 40: E002-E002.
[25]  Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol. 2020; 92: 680-682.
[26]  Zhang H, Li HB, Lyu JR, Lei XM, Li W, WuG, et al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis 2020; 96: 19-24.
[27]  Lerner A, Shoenfeld Y, Matthias T. A Review: Gluten ingestion side effects and withdrawal advantages in non-celiac autoimmune diseases. Nutr Rev. 2017; 75: 1046-1058.
[28]  Lerner A, Ramesh A, Matthias T. Are Non-Celiac Autoimmune Diseases Responsive to Gluten-Free Diet? Intrenat J Celiac Dis. 2017; 5: 164-167.
[29]  Lerner A, Matthias T. Going gluten free in non-celiac autoimmune diseases: The missing ingredient. Expert Rev Clin Immunol. 2018; 14: 873-875.
[30]  Lerner A, Matthias T. The Yin and Yang of dietary gluten transgressions in real-life scenarios of celiac patients. BMC Medicine. 2020; 18: 70-72.
[31]  Haupt-Jorgensen M, Buschard K. Can a gluten-free diet be partly protective for COVID-19 infection? APMIS 2020; 128: 558–559. DOI 10.1111/apm.13075
[32]  Chow MA, Lebwohl B, Reilly NR, Green PH. Immunoglobulin A deficiency in celiac disease. J Clin Gastroenterol. 2012; 46: 850-4.
[33]  Lerner A, Neidhöfer S, Matthias T. The gut-gut axis: Cohabitation of celiac, Crohn’s disease and IgA deficiency. Internat J Celiac Dis. 2016: 4: 68-70.
[34]  Naito Y, Takagi T, Yamamoto T, Watanabe S. Association between selective IgA deficiency and COVID-19. J Clin Biochem Nutr. 2020; 67: 122-125.
[35]  Kunz R, Minder M. COVID-19 pandemic: palliative care for elderly and frail patients at home and in residential and nursing homes. Swiss Med Wkly. 2020; 150: w20235.
[36]  Lerner A, Matthias T. Increased knowledge and awareness of celiac disease will benefit the elderly. Intern. J of Celiac Dis. 2015; 3: 112-114.
[37]  Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Lee SS. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020; 24: 4016-4026.
[38]  Heavey E. Protecting adults with celiac disease from pulmonary infections. Nursing. 2019; 49: 68-69.
[39]  Vazquez H, Smecuol E, Flores D, Mazure R, Pedreira S, Niveloni S, Mauriño E, Bai JC. Relation between cigarette smoking and celiac disease: evidence from a case-control study. Am J Gastroenterol. 2001; 96: 798-802.
[40]  Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020; 18: 20.
[41]  Lojou M, Sahakian N, Dutour A, Vanbiervliet G, Bege T, Gaborit B. Celiac Disease and Obesity: Is Bariatric Surgery an Option? Obes Surg. 2020; 30: 2791-2799.
[42]  Livshits OE, Shauol R, Reifen R, Matthias T, Lerner A. Can Celiac Disease Present Along With Childhood Obesity? Internat J of Celiac Dis. 2017; 5: 19-23.
[43]  Finer N, Garnett SP, Bruun JM. COVID-19 and obesity. Clin Obes. 2020 ; 10: e12365.
[44]  Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020; 116: 1666-1687.
[45]  Ciaccio EJ, Lewis SK, Biviano AB, Iyer V, Garan H. Cardiovascular involvement in celiac disease. World J Cardiol 2017; 9: 652-666.
[46]  Lerner A, Blank M. Hypercoagulability in celiac disease--an update. Autoimmun Rev. 2014; 13: 1138-41.
[47]  Lerner A, Agmon-Levin N, Shapira Y, Gilburd B, Reuter S, Lavi I, Shoenfeld Y. The thrombophilic network of autoantibodies in celiac disease. BMC Med. 2013; 11: 89.
[48]  Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020; 18: 1559-1561.
[49]  Levy J, Bernstein L, Silber N. Celiac disease: an immune dysregulation syndrome. Curr Probl Pediatr Adolesc Health Care. 2014; 44: 324-7.
[50]  Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of Genetic and Immunological Insights into a Model of Celiac Disease Pathogenesis. Annual Review of Immunology. 2011; 29: 493-525.
[51]  Kang CK, Han GC, Kim M, Kim G, Shin HM, Song KH, et al. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis. 2020; 97: 313-321.
[52]  Woodward J. Improving outcomes of refractory celiac disease - current and emerging treatment. Clin Exp Gastroenterol. 2016; 9: 225-36.
[53]  Slimano F, Baudouin A, Zerbit J, Toulemonde-Deldicque A, Thomas-Schoemann A, Chevrier R, et al. Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines) Cancer Treat Rev. 2020; 88: 102063.
[54]  Giorgio F, Principi M, Losurdo G, Piscitelli D, Iannone A, Barone M, et al. Seronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg? Nutrients. 2015; 7: 7486-504.
[55]  Uzzan M, Ko HM, Mehandru S, Cunningham-Rundles C. Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD). Curr Gastroenterol Rep. 2016; 18: 17.
[56]  Brandon Henry B, Isaac Cheruiyot I, Jens Vikse J, Victor Mutua V, Vincent Kipkorir V, Justin Benoit J, et al. Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis. Acta Biomed. 2020; 91: e2020008.
[57]  Askling J, Linet M, Gridley G, Halstensen TS, Ekström K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002; 123: 1428-35.
[58]  Yang J, Chen Z, Jia B. Higher COVID-19 risk for patients with cancer. MedComm. 2020; 1: 418-419.
[59]  Faye AS, Lee KE. Risk of Adverse Outcomes in Hospitalized Patients with Autoimmune Disease and COVID-19: A Matched Cohort Study from New York City. The J of Rheumatol. November 2020, jrheum.200989. Ahead of print.
[60]  Luca Elli L, Scaramella L, Lombardo V, Scricciolo A, Donedad L, Roncoroni L, Vecchi. M. Refractory celiac disease and COVID-19 outbreak: Findings from a high incidence scenario in Northern Italy. Clinics and Res in Hepatol and Gastroenterol. 2020; 44: e115-e120
[61]  Siniscalchi M , Zingone F , Savarino EV , D’Odorico A, Ciacci C. COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine. Digest and Liver Dis. 2020; 52: 1071-1075.
[62]  Zingone F, D'Odorico A, Lorenzon G, Marsilio I, Farinati F, Savarino EV. Risk of COVID-19 in celiac disease patients. Autoimm Rev. 2020; 19: 102639.
[63]  Sociedad Española de Patología Digestiva; Asociación Española de Gastroenterología. Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18). Rev Esp Enferm Dig. 2020 Mar 23.
[64]  Repici A, Maselli R, Colombo M, Roberto Gabbiadini R, Spadaccini M, Anderloni A, et al. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest Endosc. 2020; 92: 192-197.
[65] COVID-19 Clinical Insights for Our Community of Gastroenterologists and Gastroenterology Care Providers. Posted on March 15, 2020 by the American College of Gastroenterology News Team.
[66]  Walsh CM, Fishman DS, Lerner DG, NASPGHAN Endoscopy and Procedures Committee. Pediatric Endoscopy in the Era of COVID-19: A NASPGHAN Position Paper. J of Pediatr Gastroenterol and Nutr. 2020; 70: 741-750.
[67]  Murray KF, Gold BD, Shamir R, Agostoni C, Pierre-Alvarez R, Kolacek S, et al. Coronavirus Disease 2019 and the Pediatric Gastroenterologist. J Pediatr Gastroenterol Nutr. 2020; 70: 720-726.
[68]  Sinonquel P, Roelandt P, Demedts I, van Gerven L, Vandenbriele C, Wilmer A, et al. COVID-19 and gastrointestinal endoscopy: what should be taken into account? Dig Endosc. 2020; 32: 723-731.
[69]  Zuo T, Liu Q, Zhang F, Lui GC-Y, Tso EY, Yeoh YK, Chen Z, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut 2021; 70: 276-284.
[70]  Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020; 158: 1518-1519.
[71]  Zhang W, Du R-H, Li B, Zheng X-S, Yang X-L, Hu B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020; 9: 386-389.
[72]  Lerner A, Ramesh A, Matthias T. David and Goliath war revival in the enteric viruses and microbiota struggle. Potential implication for celiac disease. Microorganisms, 2019; 7: 173.
[73] Last reported on 30, Dec, 2020.
[75]  Coronavirus Covid-19 and Celiac Disease | › coronavirus. Dec 9, 2020.